Insmed
INSM
#677
Rank
HK$274.34 B
Marketcap
HK$1,273
Share price
-1.47%
Change (1 day)
123.33%
Change (1 year)

Insmed (INSM) - Total debt

Total debt on the balance sheet as of December 2025 : HK$4.59 Billion

According to Insmed's latest financial reports the company's total debt is HK$4.59 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insmed - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2025-12-31HK$4.56 B-48.82%
2024-12-31HK$8.91 B-5.15%
2023-12-31HK$9.40 B2.18%
2022-12-31HK$9.20 B92.76%
2021-12-31HK$4.77 B52.12%
2020-12-31HK$3.13 B1.5%
2019-12-31HK$3.09 B24.74%
2018-12-31HK$2.47 B471%
2017-12-31HK$0.43 B2.18%
2016-12-31HK$0.42 B118.05%
2015-12-31HK$0.19 B1.07%
2014-12-31HK$0.19 B26.3%
2013-12-31HK$0.15 B1.57%
2012-12-31HK$0.15 B6810.29%
2011-12-31HK$2.17 M70.4%
2010-12-31HK$1.27 M-20.86%
2009-12-31HK$1.61 M-90.07%
2008-12-31HK$16.24 M-38.26%
2007-12-31HK$26.3 M7.01%
2006-12-31HK$24.58 M-50.74%
2005-12-31HK$49.9 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
HK$277.19 B 5,929.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
HK$195.39 B 4,150.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$15.91 B 246.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$8.14 B 77.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$2.64 B-42.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
HK$6.00 B 30.60%๐Ÿ‡บ๐Ÿ‡ธ USA